We are a Bio-IT startup based in San Francisco and India, backed by two of the largest health care institutional investors: 8vc (
https://8vc.com/bio-it) and Optum / United Health Group (Fortune #5 company). We are an innovator in clinical research execution and work with some of the largest pharma companies to accelerate their medical innovations to market. We are currently in stealth mode and have a limited web presence, but we have recently raised over $30mn from our Seed/Series A, which is one of the largest funding rounds in our industry. Our founders are successful serial entrepreneurs, with three of their past companies leading to IPOs (VMware, MobileIron) or exits (LexentBio acquired by Roche).